Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Updated research nosology for HIV-associated neurocognitive disorders.

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE.

Neurology. 2007 Oct 30;69(18):1789-99. Epub 2007 Oct 3.

2.

Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders.

Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I; HNRC Group..

J Neurovirol. 2007;13(1):23-8.

PMID:
17454445
3.

Dementia and neurocognitive disorders due to HIV-1 infection.

Ances BM, Ellis RJ.

Semin Neurol. 2007 Feb;27(1):86-92. Review.

PMID:
17226745
4.

Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia.

Foley JM, Wright MJ, Gooding AL, Ettenhofer M, Kim M, Choi M, Castellon SA, Sadek J, Heaton RK, van Gorp WG, Marcotte TD, Hinkin CH.

Int Psychogeriatr. 2011 Jun;23(5):835-43. doi: 10.1017/S1041610210002085. Epub 2010 Nov 19.

5.

Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?

Nakazato A, Tominaga D, Tasato D, Miyagi K, Nakamura H, Haranaga S, Higa F, Tateyama M, Fujita J.

J Infect Chemother. 2014 Mar;20(3):217-9. doi: 10.1016/j.jiac.2013.10.005. Epub 2014 Jan 18.

PMID:
24462448
6.

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy.

Deutsch R, Ellis RJ, McCutchan JA, Marcotte TD, Letendre S, Grant I; HNRC Group..

AIDS. 2001 Sep 28;15(14):1898-9. No abstract available.

PMID:
11579260
7.

Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Woods SP, Moore DJ, Weber E, Grant I.

Neuropsychol Rev. 2009 Jun;19(2):152-68. doi: 10.1007/s11065-009-9102-5. Epub 2009 May 22. Review.

8.

Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV.

Chiao S, Rosen HJ, Nicolas K, Wendelken LA, Alcantar O, Rankin KP, Miller B, Valcour V.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):949-56. doi: 10.1089/AID.2012.0229. Epub 2013 Mar 20.

9.

HIV-associated neurocognitive disorders (HAND).

Elbirt D, Mahlab-Guri K, Bezalel-Rosenberg S, Gill H, Attali M, Asher I.

Isr Med Assoc J. 2015 Jan;17(1):54-9. Review.

10.

HIV-associated neurocognitive disorders: still a hot topic?

Levy I.

Isr Med Assoc J. 2015 Jan;17(1):52-3. No abstract available.

11.

HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient subgroups.

Pozniak A, Rackstraw S, Deayton J, Barber T, Taylor S, Manji H, Melvin D, Croston M, Nightingale S, Kulasegaram R, Pitkanen M, Winston A.

Antivir Ther. 2014;19(1):1-13. doi: 10.3851/IMP2563. Epub 2013 Mar 21. Review.

PMID:
23519006
12.

Emerging issues in the neuropsychology of HIV infection.

Foley J, Ettenhofer M, Wright M, Hinkin CH.

Curr HIV/AIDS Rep. 2008 Nov;5(4):204-11. Review.

13.

The HIV Dementia Scale: predictive power in mild dementia and HAART.

Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR.

J Neurol Sci. 2007 Sep 15;260(1-2):11-5. Epub 2007 May 4.

PMID:
17482212
14.

What's in a name? AIDS dementia complex, HIV-associated dementia, HIV-associated neurocognitive disorder or HIV encephalopathy.

Singh D.

Afr J Psychiatry (Johannesbg). 2012 May;15(3):172-5. doi: http://dx.doi.org/10.4314/ajpsy.v15i3.22. Review.

PMID:
22722724
15.

Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study.

Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E.

Neurology. 2016 Jan 26;86(4):334-40. doi: 10.1212/WNL.0000000000002277. Epub 2015 Dec 30.

16.

HIV-associated neurocognitive disorder.

Clifford DB, Ances BM.

Lancet Infect Dis. 2013 Nov;13(11):976-86. doi: 10.1016/S1473-3099(13)70269-X. Review.

17.

Controversies in HIV-associated neurocognitive disorders.

Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T.

Lancet Neurol. 2014 Nov;13(11):1139-51. doi: 10.1016/S1474-4422(14)70137-1. Review.

18.

Neurocognitive outcomes in pediatric HIV.

Willen EJ.

Ment Retard Dev Disabil Res Rev. 2006;12(3):223-8.

PMID:
17061290
19.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I; CHARTER Group..

Neurology. 2010 Dec 7;75(23):2087-96. doi: 10.1212/WNL.0b013e318200d727.

20.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.

Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group..

J Neurovirol. 2013 Apr;19(2):150-6. doi: 10.1007/s13365-013-0152-3. Epub 2013 Feb 14.

Supplemental Content

Support Center